Treatment of localized prostate cancer by vascular-targeted photodynamic therapy with WST11 - Abstract

Focal therapies are new options for the treatment of localized prostate cancer.

Vascular-targeted photodynamic therapy (VTP) with WST11 is one of these options. The aim of this treatment is to destroy a targeted area of the prostate by the associated action of the WST11 drug, light exposure and oxygen. The procedure is performed under general anesthesia. Fibers are introduced trans-perineally in the prostate by ultrasound guidance. The injection of WST11 is then performed with light illumination of the specific targeted area. Current data report 83% negative biopsies 6 months after treatment with good tolerance of the treatment. However, VTP still needs to be evaluated.

Written by:
Lebdai S, Martin F, Bigot P, Azzouzi AR.   Are you the author?
Service d'urologie, CHU d'Angers, 4, rue Larrey, 49933 Angers cedex 9, France.  

Reference: Prog Urol. 2014 Sep 3. pii: S1166-7087(14)00212-7.
doi: 10.1016/j.purol.2014.08.002


PubMed Abstract
PMID: 25195031

Article in French.

UroToday.com Prostate Cancer Section

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe